Evidence map›Paper›PMID 33665182›Full record

ReviewFrontiers in public health2021

Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia.

Jesús Chávez-Reyes, Carlos E Escárcega-González, Erika Chavira-Suárez, Angel León-Buitimea, Priscila Vázquez-León, José R Morones-Ramírez, Carlos M Villalón, Andrés Quintanar-Stephano, Bruno A Marichal-Cancino

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 6 pooled it
18.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 6 syntheses or guidelines pooled it, 167 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Diabetes as a risk factor for tuberculosis disease.The Cochrane database of systematic reviews · 2024
    Pooled it
  4. Passion fruit (Frontiers in nutrition · 2024
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Efficacy and safety ofFrontiers in pharmacology · 2025
    Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Observational
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jesús Chávez-ReyesDepartamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
Carlos E Escárcega-GonzálezFacultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, Nuevo León, Mexico.
Erika Chavira-SuárezUnidad de Vinculación Científica de la Facultad de Medicina, Universidad Nacional Autónoma de México en el Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
Angel León-BuitimeaFacultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, Nuevo León, Mexico.
Priscila Vázquez-LeónDepartamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
José R Morones-RamírezFacultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, Nuevo León, Mexico.
Carlos M VillalónDepartamento de Farmacobiología, Cinvestav-Coapa, Mexico City, Mexico.
Andrés Quintanar-StephanoDepartamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
Bruno A Marichal-CancinoDepartamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
Autonomous University of Aguascalientes · MXUniversidad Autónoma de Nuevo León · MXCenter for Research and Advanced Studies of the National Polytechnic Institute · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uncontrolled diabetes results in several metabolic alterations including hyperglycemia. Indeed, several preclinical and clinical studies have suggested that this condition may induce susceptibility and the development of more aggressive infectious diseases, especially those caused by some bacteria (including

Indexed as

Disease SusceptibilityAdultAgedAged, 80 and overBacterial InfectionsCOVID-19Diabetes ComplicationsFemaleHumansHyperglycemiaMaleMiddle AgedVirus DiseasesCOVID-19diabeteshyperglycemiaimmune systeminfections

Identifiers

PMID33665182
PMCPMC7921169
OpenAlexW3132900806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.